ACA vs UTHR · P/E 57, rev $2.88B vs P/E 20, rev $2.88B
Arcosa Inc (ACA) versus United Therapeutics Corporation (UTHR) — a side-by-side from cached financials, not a winner call.
Arcosa Inc (ACA) is a engineering & construction company listed on US.
United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported ACA revenue for 2025-12-31 was $2.88B. Net income was $208.4M. Revenue was up 12.2% from 2024-12-31 to 2025-12-31. ACA currently screens at market cap $4.39B and trailing P/E 56.6.
Latest reported UTHR revenue for 2024-12-31 was $2.88B. Net income was $1.20B. Revenue was up 23.6% from 2023-12-31 to 2024-12-31. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
ACA currently screens at market cap $4.39B and trailing P/E 56.6. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
Not investment advice. Open the ACA and UTHR stock pages for the full models.
Not investment advice.